Furthermore, immunoassays for HTC were developed to distinguish cancer cells from stromal cells using the CK8/18 antibody cocktail and to distinguish cells with a multidrug-resistant phenotype from sensitive cells using the ABCB1, ABCC1 and ABCG2 antibodies [140,141]. Here, ABCB1 is linked to cancer.